Allspring Global Investments
FBRX icon

Allspring Global Investments’s Forte Biosciences FBRX Stock Holding History

Allspring Global Investments’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,603
Closed -$58K – 2760
2022
Q1 		$58K Buy
1,603
+1,602
+160,200% +$60.6K ﹤0.01% 2827
2021
Q4 		$0 Buy
+1
New +$67 ﹤0.01% 2949

Other funds holding FBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Allspring Global Investments's FBRX Position: Q2 2022 in Review

Allspring Global Investments sold out of Forte Biosciences (FBRX) in Q2 2022, closing a stake of 1,603 shares — an estimated $58K sold.

Allspring Global Investments first reported a position in FBRX in Q4 2021 and held it in 2 quarters. The position peaked at $58K in Q1 2022. 39 funds tracked by Wall St. Rank hold FBRX as of Q2 2022.

  • Allspring Global Investments reported no remaining Forte Biosciences position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 1,603 Forte Biosciences shares in Q2 2022, an estimated $58K.
  • Allspring Global Investments first reported a position in Forte Biosciences in Q4 2021 and held it in 2 quarters.
  • Allspring Global Investments's Forte Biosciences position peaked at $58K in Q1 2022.
  • 39 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.